Skip to main content
Erschienen in: Clinical and Experimental Nephrology 5/2009

01.10.2009 | Original Article

Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension

verfasst von: Atsushi Takeda, Takayuki Toda, Takuma Fujii, Noriaki Matsui

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Nondipper hypertensive patients have more pronounced target organ injury. We examined whether shifting the time of dosing long-acting antihypertensive drugs from morning to bedtime reduces nocturnal blood pressure (BP) and restores normal nocturnal dipping in nondippers with essential hypertension.

Methods

We studied 71 Japanese hypertensive patients who received long-acting antihypertensive drugs once daily in the morning using 24-h ambulatory BP monitoring. After determination of circadian BP pattern, medication time was changed to bedtime only in nondippers.

Results

Among 71 patients, 36 were classified as dippers and 35 as nondippers. After shifting administration time from morning to bedtime in 34 nondippers, the office and 24-h ambulatory BP did not change, but the diurnal BP slightly increased and nocturnal BP markedly decreased. The percentages of nocturnal decline in systolic and diastolic BP increased from 2.6% to 15.5% (P < 0.0001) and 5.6% to 16.9% (P < 0.0001). Morning BP at 7 a.m.–11 a.m. did not increase by bedtime administration. The frequency of dippers increased from 0/34 (0%) to 24/34 (71%). Adding to 50% of dippers on morning administration, 86% of the hypertensive patients became dippers by deciding the medication time according to dipper status.

Conclusion

Nondippers on morning dosing can be changed to dippers by shifting administration time to bedtime, reducing nocturnal BP but not changing office BP, 24-h ambulatory BP or morning BP. In treating essential hypertensive patients, it is desirable to measure 24-h ambulatory BP as well as office BP and to decide the administration time of long-acting antihypertensive drugs to normalize nocturnal BP fall.
Literatur
1.
Zurück zum Zitat Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305–15.CrossRefPubMed Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305–15.CrossRefPubMed
2.
Zurück zum Zitat Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.CrossRef Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.CrossRef
3.
Zurück zum Zitat Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6.CrossRefPubMed Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6.CrossRefPubMed
4.
Zurück zum Zitat Gosse P, Lasserre R, Minifie C, Lemetayer P, Clementy J. Blood pressure surge on rising. J Hypertens. 2004;22:1113–8.CrossRefPubMed Gosse P, Lasserre R, Minifie C, Lemetayer P, Clementy J. Blood pressure surge on rising. J Hypertens. 2004;22:1113–8.CrossRefPubMed
5.
Zurück zum Zitat Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, et al. Circadian variation in the frequency of sudden cardiac death. Circulation. 1987;75:131–8.CrossRefPubMed Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, et al. Circadian variation in the frequency of sudden cardiac death. Circulation. 1987;75:131–8.CrossRefPubMed
6.
Zurück zum Zitat Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485–91.CrossRefPubMed Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485–91.CrossRefPubMed
7.
Zurück zum Zitat Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797–805.CrossRefPubMed Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797–805.CrossRefPubMed
8.
Zurück zum Zitat Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA. 1999;282:539–46.CrossRefPubMed Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA. 1999;282:539–46.CrossRefPubMed
9.
Zurück zum Zitat Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20:2183–9.CrossRefPubMed Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20:2183–9.CrossRefPubMed
10.
Zurück zum Zitat Deakin M, Glenny HP, Ramage JK, Mills JG, Burland WL, Williams JG. Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study. Gut. 1987;28:566–72.CrossRefPubMedPubMedCentral Deakin M, Glenny HP, Ramage JK, Mills JG, Burland WL, Williams JG. Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study. Gut. 1987;28:566–72.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Reinberg A, Pauchet F, Ruff F, Gervais A, Smolensky MH, Levi F, et al. Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma. Chronobiol Int. 1987;4:409–19.CrossRefPubMed Reinberg A, Pauchet F, Ruff F, Gervais A, Smolensky MH, Levi F, et al. Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma. Chronobiol Int. 1987;4:409–19.CrossRefPubMed
12.
Zurück zum Zitat Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y. Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study. Arterioscler Thromb. 1991;11:816–26.CrossRefPubMed Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y. Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study. Arterioscler Thromb. 1991;11:816–26.CrossRefPubMed
13.
Zurück zum Zitat Koren G, Ferrazzini G, Sohl H, Robieux I, Johnson D, Giesbrecht E. Chronopharmacology of methotrexate pharmacokinetics in childhood leukemia. Chronobiol Int. 1992;9:434–8.CrossRefPubMed Koren G, Ferrazzini G, Sohl H, Robieux I, Johnson D, Giesbrecht E. Chronopharmacology of methotrexate pharmacokinetics in childhood leukemia. Chronobiol Int. 1992;9:434–8.CrossRefPubMed
14.
Zurück zum Zitat Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368–74.CrossRefPubMed Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368–74.CrossRefPubMed
15.
Zurück zum Zitat O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet. 2006;2(8607):397. O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet. 2006;2(8607):397.
16.
Zurück zum Zitat Covic A, Goldsmith DJ. Ambulatory blood pressure measurement in the renal patient. Curr Hypertens Rep. 2002;4:369–76.CrossRefPubMed Covic A, Goldsmith DJ. Ambulatory blood pressure measurement in the renal patient. Curr Hypertens Rep. 2002;4:369–76.CrossRefPubMed
17.
Zurück zum Zitat White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens. 1999;12:806–14.CrossRefPubMed White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens. 1999;12:806–14.CrossRefPubMed
18.
Zurück zum Zitat Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 1995;8:719–26.CrossRefPubMed Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 1995;8:719–26.CrossRefPubMed
19.
Zurück zum Zitat Hermida RC, Calvo C, Ayala DE, Fernandez JR, Covelo M, Mojon A, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913–22.CrossRefPubMed Hermida RC, Calvo C, Ayala DE, Fernandez JR, Covelo M, Mojon A, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913–22.CrossRefPubMed
20.
Zurück zum Zitat Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15:205–11.CrossRefPubMed Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15:205–11.CrossRefPubMed
21.
Zurück zum Zitat Hermida RC, Calvo C, Ayala DE, Dominguez MJ, Covelo M, Fernandez JR, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 2003;42:283–90.CrossRefPubMed Hermida RC, Calvo C, Ayala DE, Dominguez MJ, Covelo M, Fernandez JR, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 2003;42:283–90.CrossRefPubMed
22.
Zurück zum Zitat Hermida RC, Calvo C, Ayala DE, Dominguez MJ, Covelo M, Fernandez JR, et al. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol Int. 2004;21:277–96.CrossRefPubMed Hermida RC, Calvo C, Ayala DE, Dominguez MJ, Covelo M, Fernandez JR, et al. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol Int. 2004;21:277–96.CrossRefPubMed
23.
Zurück zum Zitat Brandenberger G, Follenius M, Goichot B, Saini J, Spiegel K, Ehrhart J, et al. Twenty-four-hour profiles of plasma renin activity in relation to the sleep–wake cycle. J Hypertens. 1994;12:277–83.CrossRefPubMed Brandenberger G, Follenius M, Goichot B, Saini J, Spiegel K, Ehrhart J, et al. Twenty-four-hour profiles of plasma renin activity in relation to the sleep–wake cycle. J Hypertens. 1994;12:277–83.CrossRefPubMed
24.
Zurück zum Zitat Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab. 1985;60:1210–5.CrossRefPubMed Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab. 1985;60:1210–5.CrossRefPubMed
25.
Zurück zum Zitat Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130–5.CrossRefPubMed Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130–5.CrossRefPubMed
26.
Zurück zum Zitat Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure. Am J Hypertens. 1997;10:261–8.CrossRefPubMed Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure. Am J Hypertens. 1997;10:261–8.CrossRefPubMed
27.
Zurück zum Zitat Musso NR, Lotti G. Reproducibility of ambulatory blood pressure monitoring. Blood Press Monit. 1996;1:105–9.PubMed Musso NR, Lotti G. Reproducibility of ambulatory blood pressure monitoring. Blood Press Monit. 1996;1:105–9.PubMed
28.
Zurück zum Zitat The Scientific Committee. Consensus document on non-invasive ambulatory blood pressure monitoring. J Hypertens. 1990;8(Suppl 6):S135–40. The Scientific Committee. Consensus document on non-invasive ambulatory blood pressure monitoring. J Hypertens. 1990;8(Suppl 6):S135–40.
29.
Zurück zum Zitat Van Ittersum FJ, Ijzerman RG, Stehouwer CD, Donker AJ. Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressures during waking and sleeping? J Hypertens. 1995;13:1053–8.CrossRefPubMed Van Ittersum FJ, Ijzerman RG, Stehouwer CD, Donker AJ. Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressures during waking and sleeping? J Hypertens. 1995;13:1053–8.CrossRefPubMed
30.
Zurück zum Zitat Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, et al. International database on ambulatory blood pressure monitoring in relation to cardiovascular outcomes (IDACO) investigators: prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.CrossRefPubMed Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, et al. International database on ambulatory blood pressure monitoring in relation to cardiovascular outcomes (IDACO) investigators: prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.CrossRefPubMed
Metadaten
Titel
Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension
verfasst von
Atsushi Takeda
Takayuki Toda
Takuma Fujii
Noriaki Matsui
Publikationsdatum
01.10.2009
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 5/2009
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0184-4

Weitere Artikel der Ausgabe 5/2009

Clinical and Experimental Nephrology 5/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.